The Trade Desk (NASDAQ:TTD – Get Free Report) has been given a consensus rating of “Hold” by the thirty-seven brokerages that are presently covering the stock, Marketbeat.com reports. Four analysts have rated the stock with a sell recommendation, eighteen have assigned a hold recommendation, fourteen have assigned a buy recommendation and one has issued a […]

TScan Therapeutics, Inc. (NASDAQ:TCRX – Get Free Report) has received a consensus recommendation of “Hold” from the six brokerages that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and three have given a buy recommendation to the company. The average […]

Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the fifteen ratings firms that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, twelve have given a buy recommendation and one has […]

CytomX Therapeutics, Inc. (NASDAQ:CTMX – Get Free Report) has been given a consensus rating of “Moderate Buy” by the eight research firms that are covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1 year price […]

Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) have been given a consensus rating of “Moderate Buy” by the five brokerages that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation, two have issued a buy recommendation and […]

Shares of ZoomInfo Technologies Inc. (NASDAQ:ZI – Get Free Report) have been given an average rating of “Hold” by the ten brokerages that are presently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, seven have issued a hold recommendation and two have assigned a buy […]

Shares of Beta Bionics, Inc. (NASDAQ:BBNX – Get Free Report) have been given an average recommendation of “Moderate Buy” by the eleven brokerages that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation, six have assigned a buy recommendation and […]

Shares of ProQR Therapeutics N.V. (NASDAQ:PRQR – Get Free Report) have received an average recommendation of “Moderate Buy” from the eight research firms that are currently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and six have given a buy recommendation […]

Marvell Technology, Inc. (NASDAQ:MRVL – Get Free Report) has received a consensus rating of “Moderate Buy” from the thirty-six analysts that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, eight have given a hold recommendation, twenty-five have issued a buy recommendation and two have issued […]

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) has received an average rating of “Moderate Buy” from the nine research firms that are currently covering the company, Marketbeat reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and seven have assigned a buy rating to […]